# Bavarian Nordic clinical trials: 58 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 58 trials with Bavarian Nordic as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Bavarian Nordic: 58 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/bavarian-nordic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 58
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 58, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888088 | Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults | Bavarian Nordic | Phase 1 | Not yet recruiting | Epstein Barr Virus (EBV) Infection | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888088) |
| March 12, 2026 | NCT07467707 | An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults | Bavarian Nordic | Phase 3 | Recruiting | Chikungunya Virus | 6,144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467707) |
| September 30, 2025 | NCT07199569 | Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells | Bavarian Nordic | Phase 2 | Active not recruiting | Monkeypox (Mpox) | 970 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07199569) |
| June 4, 2025 | NCT07003984 | A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. | Bavarian Nordic | Phase 3 | Active not recruiting | Chikungunya Virus | 720 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07003984) |
| March 28, 2025 | NCT06899802 | A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine | Bavarian Nordic | Phase 2 | Active not recruiting | Encephalitis | 411 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06899802) |
| August 12, 2024 | NCT06549530 | Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to... | Bavarian Nordic | Phase 2 | Active not recruiting | Monkeypox (Mpox) | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06549530) |
| August 23, 2023 | NCT06007183 | Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster Vaccination | Bavarian Nordic | Phase 3 | Active not recruiting | Chikungunya Virus Infection | 715 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06007183) |
| April 27, 2022 | NCT05349617 | Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years | Bavarian Nordic | Phase 3 | Completed | Chikungunya Virus | 413 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05349617) |
| April 14, 2022 | NCT05329220 | ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 | Bavarian Nordic | Phase 3 | Completed | COVID-19 Disease | 4,205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05329220) |
| February 14, 2022 | NCT05238025 | MVA-BN-RSV Vaccine Trial | Bavarian Nordic | Phase 3 | Terminated | Respiratory Syncytial Virus Infections | 20,419 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05238025) |
| October 14, 2021 | NCT05077267 | ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects | Bavarian Nordic | Phase 2 | Completed | COVID-19 Disease | 197 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05077267) |
| October 8, 2021 | NCT05072080 | A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) | Bavarian Nordic | Phase 3 | Completed | Chikungunya Virus | 3,258 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05072080) |
| October 4, 2021 | NCT05065983 | A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine | Bavarian Nordic | Phase 2 | Completed | Chikungunya Virus | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05065983) |
| February 12, 2021 | NCT04752644 | Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults | Bavarian Nordic | Phase 2 | Completed | RSV Infection | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04752644) |
| January 29, 2020 | NCT04246671 | TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer | Bavarian Nordic | Phase 1 | Completed | Chordoma, HER2-positive Breast Cancer | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04246671) |
| October 22, 2019 | NCT04134312 | A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer | Bavarian Nordic | Phase 1 | Completed | Solid Metastatic Tumor | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04134312) |
| October 18, 2019 | NCT04131595 | Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects | Bavarian Nordic | Phase 1 | Completed | Equine Encephalitis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04131595) |
| June 20, 2019 | NCT03992872 | Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) | Bavarian Nordic | Phase 2 | Completed | Chikungunya | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03992872) |
| October 9, 2018 | NCT03699124 | Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial | Bavarian Nordic | Phase 3 | Completed | Smallpox | 1,129 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03699124) |
| August 14, 2018 | NCT03628716 | CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer | Bavarian Nordic | Phase 2 | Completed | Bladder Cancer | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03628716) |
| July 23, 2018 | NCT03595228 | BN Brachyury and Radiation in Chordoma | Bavarian Nordic | Phase 2 | Completed | Chordoma | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03595228) |
| March 30, 2018 | NCT03483961 | Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults | Bavarian Nordic | Phase 2 | Completed | Chikungunya Virus Infection | 445 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03483961) |
| March 21, 2018 | NCT03472014 | Special Access Program IMVAMUNE® | Bavarian Nordic | Phase 4 | Completed | Vaccination | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03472014) |
| November 22, 2017 | NCT03349983 | Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) | Bavarian Nordic | Phase 1 | Completed | Safety Issues | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03349983) |
| July 18, 2017 | NCT03220737 | VAXCHORA Pediatric Study to Assess Safety and Immunogenicity | Bavarian Nordic | Phase 4 | Completed | Cholera (Disorder) | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03220737) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 17 |
| Phase 1/2 | 2 |
| Phase 2 | 22 |
| Phase 3 | 14 |
| Phase 4 | 2 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 49 |
| Active not recruiting | 5 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Smallpox | 11 |
| Chikungunya Fever | 7 |
| HIV Infections | 6 |
| Cholera | 5 |
| Respiratory Syncytial Virus Infections | 5 |
| Neoplasm Metastasis | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Prostatic Neoplasms | 2 |
| Mpox, Monkeypox | 2 |
| Breast Neoplasms | 2 |
| Encephalomyelitis, Equine | 2 |
| Dermatitis, Atopic | 2 |
| Chordoma | 2 |
| Neoplasms | 1 |
| Epstein-Barr Virus Infections | 1 |
| Infections | 1 |
| Encephalitis | 1 |
| Rhinitis, Allergic, Seasonal | 1 |
| Urinary Bladder Neoplasms | 1 |
| Typhoid Fever | 1 |
| Measles | 1 |
| Virus Diseases | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pediatric pulmonology practices in the United States](https://specstream.ai/data/businesses/pediatric-pulmonology-practices/united-states)
- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [Cocktail bars in the United States](https://specstream.ai/data/businesses/cocktail-bars/united-states)
- [West African restaurants in the United States](https://specstream.ai/data/businesses/west-african-restaurants/united-states)
- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
- [Industrial cleaning companies in the United States](https://specstream.ai/data/businesses/industrial-cleaning-companies/united-states)
